Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jaime R Merchan

3PUBLICATIONS
42CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Jun 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumors.

|Jan 16, 2024
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study.

Robert J Motzer, Camillo Porta, Masatoshi Eto

|Aug 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer.

Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky

Pageof 1

Frequent Collaborators

1 joint publications

Robert J Motzer

1 joint publications

Thomas Powles

1 joint publications

Viktor Grünwald

1 joint publications

Thomas E Hutson

1 joint publications

Sun Young Rha

1 joint publications

Jeffrey C Goh

1 joint publications

Aly-Khan A Lalani

1 joint publications

Ugo De Giorgi

1 joint publications

Sung-Hoo Hong

1 joint publications

Howard Gurney

Frequent Collaborators

1 joint publications

Robert J Motzer

1 joint publications

Thomas Powles

1 joint publications

Viktor Grünwald

1 joint publications

Thomas E Hutson